Autism in children
Exam Tips
- In OSCE/viva answers, state that diagnosis is clinical and multidisciplinary; there is no single confirmatory blood test or scan.
- For preschool suspicion, prioritise cross-setting red flags: social reciprocity differences, communication differences, and restricted/repetitive or sensory features.
- Mention that girls and children with learning disability are at risk of under-recognition; actively ask about masking and school reports.
- High-yield safety point: do not promise medication for core autism symptoms; medicines are for specific coexisting problems/risk behaviours and need close monitoring.
- Always include comorbidity screening (sleep, epilepsy, anxiety/depression, ADHD, constipation, nutrition, safeguarding) in management plans.
- If asked about causation, avoid outdated myths; explain multifactorial neurodevelopmental aetiology with strong genetic contribution and selected environmental risks (for example prenatal valproate).
Definition
Autism in children is a lifelong neurodevelopmental condition characterized by persistent differences in social communication and reciprocal interaction, together with restricted, repetitive patterns of behaviour, interests, or sensory responses. Features begin in early development (even if fully recognised later) and must cause clinically significant functional impact across everyday settings such as home, school, and community.
Pathophysiology
Autism is best understood as a heterogeneous neurodevelopmental phenotype rather than a single disease. Current models describe polygenic and, in some children, monogenic/chromosomal contributions that alter early brain development (including synaptogenesis, cortical connectivity, and excitatory-inhibitory signalling), producing differences in social cognition, language pragmatics, sensory processing, and behavioural flexibility. Gene-environment interactions are likely important (for example, prematurity and selected prenatal exposures), with wide inter-individual variation in intellectual profile, language trajectory, and co-occurring neurodevelopmental or mental health conditions. See Figure: social-communication and restricted-behaviour domains in standard child psychiatry text diagrams (ASD chapter) and developmental red-flag timelines in UK autism recognition guidance.
Risk Factors
- Family history of autism or other neurodevelopmental disorders (higher sibling recurrence risk; higher concordance in monozygotic twins)
- Chromosomal/genetic conditions (for example Fragile X syndrome, Down syndrome, tuberous sclerosis, neurofibromatosis type 1)
- Preterm birth (<35 weeks gestation)
- Prenatal sodium valproate exposure
- Neonatal/epileptic encephalopathy (including infantile spasms)
- Neurodevelopmental comorbidity (for example learning disability, ADHD)
- Birth-related CNS injury/malformation (for example cerebral palsy)
- Parental severe mental illness (schizophrenia-spectrum or affective disorder)
Clinical Features
Symptoms
- Delayed language development, language regression, or reduced functional communication
- Reduced response to name despite normal hearing history
- Limited shared enjoyment, reduced social reciprocity, and difficulty with peer interaction
- Reduced pretend play and imaginative flexibility
- Insistence on sameness, distress with change, and rigid routines
- Restricted or unusually intense interests
- Sensory hyper- or hypo-reactivity (sound, texture, taste, smell), including restricted food patterns
- Sleep disturbance, anxiety symptoms, or emotional dysregulation as common coexisting problems
Signs
- Reduced or atypical eye contact, gesture use, and facial-expression integration during interaction
- Limited joint attention (for example poor gaze switching, limited pointing/showing to share interest)
- Echolalia, atypical prosody/intonation, or pronoun reversal
- Repetitive motor behaviours (for example hand flapping, rocking, spinning, finger flicking)
- Repetitive or stereotyped play (for example repetitive object manipulation)
- Observed social communication differences across more than one setting (home/nursery/school)
Investigations
Management
Lifestyle Modifications
- Provide clear diagnosis explanation and strengths-needs profile to child/young person and family; co-produce care plan
- Early, structured support in education (SENCO/EHCP where needed), communication support, and predictable routines
- Parent/carer support and skills programmes for understanding behaviour and reducing distress
- Environmental and sensory adaptations (for example noise reduction, visual schedules, transition planning)
- Active screening and treatment of coexisting conditions (sleep, anxiety, ADHD, epilepsy, constipation, feeding problems)
- Safeguarding vigilance: bullying, exploitation risk, and carer strain
Pharmacological Treatment
Sleep dysregulation in autistic children (specialist or shared-care use)
- Melatonin prolonged-release (Slenyto) 2 mg 30-60 minutes before bedtime; if inadequate, increase to 5 mg, then up to 10 mg nightly
Use only after behavioural sleep interventions fail; licensed in UK for insomnia in children/adolescents 2-18 years with ASD/Smith-Magenis syndrome. Review efficacy and adverse effects regularly.
Severe aggression/challenging behaviour (time-limited, specialist-led, after psychosocial strategies)
- Risperidone oral: if <50 kg start 0.25 mg once daily; if >=50 kg start 0.5 mg once daily; titrate cautiously on alternate days (usual around 0.5 mg/day and 1 mg/day respectively; short-term use)
No drug treats core autism features. Antipsychotics should be reserved for severe risk of harm and reviewed frequently. Monitor weight/BMI, blood pressure, glucose/lipids, extrapyramidal effects, and prolactin-related effects. Discuss sedation and metabolic risk. Use is often off-label in autism-specific behaviour; specialist child psychiatry/pediatrics oversight is essential.
Complications
- Under-recognised comorbid neurodevelopmental disorders (for example ADHD, learning disability, developmental coordination disorder)
- Mental health disorders (anxiety, depression, OCD symptoms) and risk of self-harm/suicidality
- Epilepsy and sleep disorders
- Nutritional deficiency from restrictive eating; constipation and continence problems
- Educational exclusion, bullying, social isolation, and reduced long-term independence/employment opportunities
- Family/carer stress and safeguarding vulnerabilities (including exploitation and abuse)
Prognosis
Autism is lifelong, but developmental trajectory is variable and not fully predictable at diagnosis. Earlier recognition, communication support, and proactive management of comorbidities improve functional outcomes; language development and average-range non-verbal cognitive ability are associated with better long-term social and adaptive outcomes. Core difficulties may lessen in severity over time for many children, but risk of mental health morbidity and avoidable health inequality persists without sustained support.
Sources & References
🏥BMJ Best Practice(4)
✅NICE Guidelines(1)
- Autism in children[overview]
📖Textbook References(12)
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1054)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1416)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 396)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1147)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 145)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 146)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 934)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 934)[context]
- Oxford Handbook of Clinical Diagnosis (Huw Llewelyn, Hock Aun Ang, Keir Lewis etc.) (Z-Library).pdf(pp. 345, 346)[context]
- Oxford Handbook of Clinical Diagnosis (Huw Llewelyn, Hock Aun Ang, Keir Lewis etc.) (Z-Library).pdf(pp. 356, 357)[context]
- [Oxford Medical Handbooks] Ian Wilkinson, Tim Raine, Kate Wiles, Anna Goodhart, Catriona Ha - Oxford Handbook of Clinical Medicine (2017, Oxford University Press) - libgen.li.pdf(pp. 304, 305)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1113)[context]